Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Use of health care services by patients with co-occurring severe mental illness and substance use disorders.

Kêdoté MN, Brousselle A, Champagne F.

Ment Health Subst Use. 2008 Sep 19;1(3):216-227.

2.

Comorbid depression and substance abuse among safety-net clients in Los Angeles: a community participatory study.

Chang ET, Wells KB, Gilmore J, Tang L, Morgan AU, Sanders S, Chung B.

Psychiatr Serv. 2015 Mar 1;66(3):285-94. doi: 10.1176/appi.ps.201300318. Epub 2014 Dec 1.

3.

Probability and predictors of treatment-seeking for substance use disorders in the U.S.

Blanco C, Iza M, Rodríguez-Fernández JM, Baca-García E, Wang S, Olfson M.

Drug Alcohol Depend. 2015 Apr 1;149:136-44. doi: 10.1016/j.drugalcdep.2015.01.031. Epub 2015 Feb 9.

4.
5.

Ethnicity and gender comparisons of health consequences in adults with alcohol dependence.

Chartier KG, Hesselbrock MN, Hesselbrock VM.

Subst Use Misuse. 2013 Feb;48(3):200-10. doi: 10.3109/10826084.2013.747743. Epub 2013 Jan 10.

6.

Undiagnosed Drug Misuse among Admissions to Psychiatric Day Treatment and Prediction of Early Exit.

Magura S, Spybrook J, Rosenblum A, Fong C, Villano C, Vogel HS, Betzler T.

Open Addict J. 2010;3:102-108.

7.

Treating depression and substance use: a randomized controlled trial.

Hunter SB, Watkins KE, Hepner KA, Paddock SM, Ewing BA, Osilla KC, Perry S.

J Subst Abuse Treat. 2012 Sep;43(2):137-51. doi: 10.1016/j.jsat.2011.12.004. Epub 2012 Feb 1.

8.

The availability of integrated care in a national sample of therapeutic communities.

Dye MH, Roman PM, Knudsen HK, Johnson JA.

J Behav Health Serv Res. 2012 Jan;39(1):17-27. doi: 10.1007/s11414-011-9251-1.

9.

Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence.

Hobbs JD, Kushner MG, Lee SS, Reardon SM, Maurer EW.

Am J Addict. 2011 Jul-Aug;20(4):319-29. doi: 10.1111/j.1521-0391.2011.00140.x. Epub 2011 May 31. Erratum in: Am J Addict. 2012 May-Jun;21(3):E1.

10.

Application of a standardized assessment methodology within the context of an evidence-based treatment for substance abuse and its associated problems.

Allen DN, Donohue B, Sutton G, Haderlie M, Lapota H.

Behav Modif. 2009 Sep;33(5):618-54. doi: 10.1177/0145445509343284.

11.

Substance abuse detoxification and residential treatment among Medicaid-enrolled adults: rates and duration of subsequent treatment.

Stein BD, Kogan JN, Sorbero M.

Drug Alcohol Depend. 2009 Sep 1;104(1-2):100-6. doi: 10.1016/j.drugalcdep.2009.04.008. Epub 2009 May 29.

12.

Co-occurring disorders in substance abuse treatment: issues and prospects.

Flynn PM, Brown BS.

J Subst Abuse Treat. 2008 Jan;34(1):36-47. Epub 2007 Jun 15. Review.

13.

Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder.

Book SW, Thomas SE, Randall PK, Randall CL.

J Anxiety Disord. 2008;22(2):310-8. Epub 2007 Mar 12.

14.

Role of social support and self-efficacy in treatment outcomes among clients with co-occurring disorders.

Warren JI, Stein JA, Grella CE.

Drug Alcohol Depend. 2007 Jul 10;89(2-3):267-74. Epub 2007 Feb 27.

15.

Supplemental Content

Support Center